Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,152.93
+0.49000.04%
Post-market: 1,153.700.7697+0.07%18:43 EDT
Volume:4.55M
Turnover:5.24B
Market Cap:1.09T
PE:38.70
High:1,157.60
Open:1,150.00
Low:1,140.27
Close:1,152.44
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:2.46
T/O Rate:0.48%
Dividend:6.69
Dividend Rate:0.58%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:32.17
PE(LYR):50.24

Loading ...

Eli Lilly May Raise Stake in Scribe Therapeutics to 10.9% Stake Through IPO

MT Newswires Live
·
Jul 20

Scribe Therapeutics - IPO Price Expected Between $13 and $15 Per Share - SEC Filing

Reuters
·
Jul 20

Scribe Therapeutics Inc - Eli Lilly Has Indicated Interest in Purchasing Co's Shares of Common Stock at IPO Price

THOMSON REUTERS
·
Jul 20

AtaiBeckley downgraded to Hold from Buy at Berenberg

TIPRANKS
·
Jul 20

Almirall Says EMA Accepts Filing for Ebglyss Pediatric Use in Atopic Dermatitis

Reuters
·
Jul 20

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Jul 20

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Eli Lilly & Co (LLY)

TIPRANKS
·
Jul 19

AtaiBeckley downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
Jul 18

Eli Lilly & Co (LLY) Gets a Hold from Berenberg Bank

TIPRANKS
·
Jul 18

Lilly Expands ALS Pipeline With Long‑Term Safety Study for LY4256984

TIPRANKS
·
Jul 18

Novo Nordisk to Launch Lower-cost Ozempic Copy in South Africa

Reuters
·
Jul 18

Eli Lilly not Seen at Risk from Indian Generic Glp-1s

Dow Jones
·
Jul 18

Eli Lilly Long-Term GLP-1 Franchise Faces Limited Generic Threat, UBS Says

MT Newswires Live
·
Jul 17

7 Stocks that actually play defence: Jon Erlichman

Bloomberg
·
Jul 17

Eli Lilly’s $3.8 Billion Psychedelic Bet Could Reshape Neuroscience!

Smartkarma
·
Jul 17

AtaiBeckley (ATAI) Agrees To Eli Lilly Buyout With Milestone Upside For Shareholders

Simply Wall St.
·
Jul 17

PRESS Digest-british Business - July 17

Reuters
·
Jul 17

AtaiBeckley downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
Jul 17

Biotech M&A : Psychedelics' Coming as Eli Lilly's AtaiBeckley Acquisition Sets a Valuation Benchmark

Smartkarma
·
Jul 17

Eli Lilly Likely to See More Momentum in GLP-1 Pipeline, UBS Says

MT Newswires Live
·
Jul 17